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Abstract:  Background: Diphthe-
ria is an acute toxic infection which 
is associated with a high morbidity 
and mortality and can pose man-
agement challenges especially in 
the absence of proper diagnostic 
and therapeutic facilities. 
Case report: A.S. was a 13 year 
old girl who presented with fever 
of five days duration, dysphagia 
and neck swelling of 4 days dura-
tion and sore throat and hoarse 
voice of 3days duration.  Her ill-
ness started a day after returning 
from a 4-day holiday youth camp. 
She received only oral polio vac-
cine immunization in childhood. 
Significant physical examination 
findings included a swollen neck, a 
greyish membrane covering the 
soft palate and uvula with haemor-
rhagic spots. The pharynx, anterior 
nares and the nasal turbinates were 
inflamed and erythematous. 
A working diagnosis of respiratory 
diphtheria was made. Throat swab 
microscopy showed club shaped 
Gram positive baccilli. Appropri-
ate culture medium for C. diphthe-
ria was not available.  
She received intravenous crystal-
line penicillin and metronidazole 
and lateroral erythromycin in an 
isolated ward. On the 6th day of 
admission she developed cardiac 
and neurologic complications– 
bradycardia (PR=40bpm),  
hypotension (BP=70/40mmHg), 
drooling of saliva and paraparesis. 
Electrocardiography confirmed a 
complete heart block. She died on 
the 11th day of admission while 
efforts were being made to raise 
funds for a cardiac pace maker.  
Conclusion: Management of this 
vaccine preventable disease re-
quires a high index of suspicion 
and diphtheria antitoxin should be 
made readily available. 
Introduction 
 
Diphtheria is an acute toxic infection caused by Coryne-
bacterium species, typically Corynebacterium diphthe-
riae and rarely toxigenic strains of Corynebacterium 
ulcerans1,2,3. The classic disease affects the upper respi-
ratory tract with the formation of an adherent gray-white 
pseudomembrane in the infected place followed by sys-
temic symptoms caused by elaboration of an exotoxin 
produced by the bacillus1,4. The disease progresses rap-
idly with a case fatality rate as high as >20% in acute 
disease states if there is no sufficient diagnostic proce-
dure and therapy option1. Therefore it requires a high 
index of suspicion. The most dominant factor causing 
death is myocarditis and diphtheria myocarditis inci-
dences related to nasopharyngeal diphtheria is 10-20% 
with a death rate as high as 50-60%5. 
 
The emergence of immunization program changed the 
epidemiology of the disease and reduced its prevalence 
worldwide. In the Western world, diphtheria is near 
eradication level in most countries6. Also, in many Afri-
can countries with a high diphtheria immunization cov-
erage rate, the incidence of diphtheria has decreased by 
>95% across the region in the past 10 years6. In Nigeria 
also, reported cases of diphtheria has been declining 
even with just low to moderate coverage with DPT3.7 
Accordingly, there has been no reported case from  
Our centre in the past 10 years. 
 
However, recently there are pockets of sporadic cases 
being reported in Nigeria. Sadoh et al8 reported nine 
cases of diphtheria in children who were aged betwen 
11months and 10years in the University of Benin Teach-
ing Hospital (UBTH) between 2008 and 2010, while 
Oyeyemi et al9 reported ten cases of diphtheria in chil-
dren aged 3-13years in the Federal Medical Centre 
Katsina on two clusters of diphtheria outbreak betwe n 
2009 and 2010 involving three contiguous local govern-
ment area in Katsina State. In this case we report a 13 
year old girl who died from probable diphtheria myocar-
ditis and the diagnostic and management challenges 
encountered. 
 
Case Report  
 
AS was a 13 year old girl who presented at the Children 
Out Patient Clinic of the    University of Port Harcourt 
Teaching Hospital with complaints of fever of five  
days duration, dysphagia and neck swelling of four days  
duration, sore throat and hoarse voice of three days  
duration. Her illness started a day after returning from a 
four-day holiday youth camp. She received amoxicillin 
capsules before presentation. She had never been immu-
nized except for Oral Polio Vaccines which she received 
on National Immunization Days (NIDs).  
 
Physical examination revealed a lethargic child in pain-
ful distress with a bull neck, hoarse voice, and drooling 
saliva. Throat inspection showed a thick greyish mem-
brane covering most part of the soft palate and hanging 
down over the uvula with areas of haemorrhagic spots. 
The pharynx was erythematous, the anterior nares and 
the nasal turbinates were inflamed and plugged with 
blood crusts. (Fig 1) She had a good volume and regular 
pulse with a rate of 82 beats per minute, a blood  
pressure of 100/70mmhg and normal heart sounds. She 
had no neurological deficits. 
 
Fig 1: Greyish  
adherent membrane 
in the soft palate and 
uvula, and the haem-
orrhagic exudates in 




A diagnosis of probable respiratory diphtheria was 
made. Microscopy of the throat swab and swab of the 
anterior nares showed club shaped Gram positive rods. 
Culture using Tellurite salt agar could not be done as 
this was not available. She was reviewed by the Otorhi-
nolaryngologist while the State Disease Surveillance and 
Notification (DSN) unit was notified.  
 
She was nursed in an isolation room, received intrave-
nous crystalline penicillin at 0.4MU/kg/day in 4 divided 
doses, intravenous Metronidazole at 8mg/kg/dose every 
8hours, intra venous fluid, oral toileting with saline wa-
ter and bed rest. All close contacts were counseled spe-
cially on the need to immunize all under-5 children 
whose last DPT dose was more than 12 months ago and 
were placed on Tablets Erythromycin – 500mg qds for 
two weeks.  
 
By the 6th day of admission, she developed cardiovascu-
lar complications – bradycardia (PR=40bpm) and  
hypotension (BP=70/40Hg). She received 20mls/kg of 
normal saline over 30minutes, intravenous hydrocorti-
sone and Atropine with no apparent clinical improve-
ment. Her condition deteriorated and by the 7th day of 
admission her pulse rate dropped further down to 24bpm 
and the power in the lower limbs was reduced to grade 
two. A diagnosis of Diphtheria Toxic cardiomyopathy 
(Heart Block) and neuropathy (Para paresis) was made. 
An electrocardiogram confirmed a Complete Heart 
Block. (Fig 2) Parents were counselled on the need for 
an urgent pacemaker. Efforts were ongoing to raise fund
for a pacemaker before she died on the 11th day of  
admission. 
Fig 2: ECG tracing of 
AS showing complete 
dissociation of the p 
wave and QRS com-
plex which are wid-
ened (172ms), idio-
ventricular rhythm 
with rate of 25/mm 




Diphtheria is an acute toxic infection caused by Coryne-
bacterium diphtheriae, an aerobic, non-encapsulated, 
Gram positive bacillus.1C. diphtheriae is an exclusive 
inhabitant of human mucous membranes and skin. It 
spreads primarily by airborne respiratory droplets, direct 
contact with respiratory secretions or exudates from 
infected skin lesion. Incidence peaks during the dry sea-
son with majority of the cases occurring in unimmu-
nized children below 15 years of age. Diphtheria occurs 
by entry of C. diphtheriae into the nose or mouth. After 
a 2-4 day incubation period, toxins are secreted which 
leads to toxin-mediated tissue necrosis. This coupled 
with local inflammatory response produces patchy exu-
dates which later forms fibrinous exudates and a tough 
adherent membrane.4 Respiratory embarrassment may 
follow extension of disease into larynx or tracheobron-
chial tree. 
 
Our patient never had DPT vaccine and hadjust return d 
from a crowded youth camp. These are strong risk fac-
tors for respiratory diphtheria. She also presented with 
features typical of probable respiratory diphtheria like 
sore throat and dysphagia, progressive neck swelling, 
haemorrhagic and inflamed nasal turbinates and an ad-
herent greyish white membrane hanging down the phar-
ynx. The early presentation and short duration of these 
symptoms confirms the short incubation period and 
rapid progression of the disease as this child at presenta-
tion within five days of disease onset was already very 
ill and lethargic.  
 
Complications remain the greatest cause of morbidity 
and mortality following infection with diphtheria. Com-
plications secondary to the elaborated diphtheria toxin 
are the most common. Toxic cardiomyopathy most com-
monly occur in the second week of the disease but can 
appear as early as the first or as late as the sixth week of 
illness1,10. Toxic cardiomyopathy occurs in 10–25% of 
patients with respiratory diphtheria and is responsible 
for 50–60% of deaths1. Neurologic complications appear 
after a variable latent period, are predominantly bilateral 
and are motor rather than sensory and usually resolv  
completely. Paralysis of the soft palate is common and
generally appears in the third week. Our patient devel-
oped features of myocarditis by the second week of dis-
ease onset and bilateral motor weakness of the lower 
limbs by the third week which is in line with disea 
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progression. This early onset of cardiac manifestation is 
associated with rapid disease progression and is a poor 
prognostic feature as was the case of our patient. Drool-
ing of saliva and hoarse voice in this patient may be due 
to sore throat and dysphagia or to paralysis of the soft 
palate. 
 
A diagnosis of diphtheria may be described as 
“probable” or “confirmed”. It is probable if the case 
meets the clinical description or confirmed if a probable 
case is laboratory confirmed or linked epidemiologically 
to a laboratory confirmed case. A clinical description is 
an illness characterized by laryngitis or pharyngitis or 
tonsillitis, and an adherent membrane on the tonsils, 
pharynx and/or nose. However, persons with positive C. 
diphtheriae cultures and not meeting the clinical de-
scription (i.e. asymptomatic carriers) should not be re-
ported as probable or confirmed diphtheria cases. Our 
patient met the criteria for probable diphtheria but could 
not be confirmed. Our centre and many others in Nigeria 
lack the appropriate capacity and skills for the isolation 
of this organism and this does have several deleterious 
effects on the management and surveillance of this  
vaccine preventable disease.  
 
A lot of challenges were encountered in the management 
of this patient. Once diphtheria is suspected, manage-
ment entails isolation of the patient, use of specific anti-
toxin and antibiotics, management of complications, 
supportive care and chemoprophylaxis for close contacts 
of patient. The first management challenge was lackof 
specific diphtheria antitoxin. The use of specific anti-
toxin is vital in halting disease progression. Antitox n 
can neutralize circulating toxin or toxin that is absorbed 
to cells but is ineffective once cell penetration has oc-
curred. Specific antitoxin is the main stay of therapy and 
should be administered as early as possible by intrave-
nous route and in a dosage sufficient to neutralize the 
free toxin. Unfortunately as important as this is in the 
treatment of patient with diphtheria this anti toxin is 
unavailable in the country. Only a probable diagnosis 
could be made in this case as it could not be bacte-
riologically confirmed by the appropriate culture  
medium.  This challenge may not be limited to our cen-
tre as many other centres contacted to assist with the 
culture also admitted not having the culture medium. 
 
Antibiotics are indicated to clear the causative organism 
and thereby halt toxin production, and prevent transmis-
sion of organisms to contacts. Our patient received ntra 
venous crystalline penicilline and metronidazole which 
have very good coverage for diphtheria but did not 
respond to it. This was probably because the disease h  
reached an advanced stage before presentation and 
elaborated toxins may have fixed to tissues which are 
not affected by antibiotics. Management of complica-
tions was also challenging.  Our case developed both
cardiac and neurologic complications both of which may 
have contributed to the mortality.  Although she was 
diagnosed of having complete heart block, lack of funds 
and unavailability of the pacemaker made this manage-
ment option not available 
 
Primary prevention in form of active immunization as
DPT vaccine at 6,10, 14 weeks of age and booster dose
at 15-18 months and again between 4-6 years of age is 
recommended. The National Programme on Immuniza-
tion (NPI) presently does not provide booster doses but 
a high coverage rate in infancy provides significant dis-
ease protection. Unfortunately, our case received neither 
the primary vaccine nor booster dose. This buttresses the 
need to reinforce and ensure full coverage of primary 
immunization by checking immunization cards as a re-
quirement for school enrolment. 
 
All household contacts and those who have had intimate 
physical contact with a patient are closely monitored for 
illness through the 7-day incubation period. Antibiotic 
prophylaxis is given, regardless of immunization status 
using erythromycin (40-50 mg/kg/day) for 7-14 days or 
a single injection of benzathine penicillin.1 This was 
done for all close contacts of our patient including the 
managing team. Unfortunately, it was not possible to 
trace the asymptomatic carrier from whom our patient 
contracted the disease, neither was it possible to trace 
other adolescents that participated in the youth camp for 






In conclusion, diphtheria, a vaccine preventable disease 
(VPD) is a disease with rapid progression and requis a 
high index of suspicion. Facilities necessary for the di-
agnosis and treatment of this disease especially diphthe-
ria specific antitoxin should be made readily available in 
Nigeria. Parents and caregivers of children should uti ize 
the opportunity of free immunizations to vaccinate th ir 
children, for indeed, prevention is better than cure.  
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